Searchable abstracts of presentations at key conferences in endocrinology

ea0009p112 | Endocrine tumours and neoplasia | BES2005

Implications of severe hyponatraemia in neurosurgical patients

Sherlock M , O'Sullivan E , Agha A , Behan L , Finucane F , Owens D , Rawluk D , Thompson C

Hyponatraemia is a well-recognised neurosurgical complication, but the incidence and complications are unknown.Objective : We aimed to define the incidence, pathophysiology and effects of significant hyponatraemia following neurosurgical admissions.Methods: All neurosurgical patients with significant hyponatraemia (plasma sodium <130 millimol per litre) between January 2002 and September 2003 were identified from computerised la...

ea0009p117 | Endocrine tumours and neoplasia | BES2005

The incidence and pathophysiology of hyponatraemia after subarachnoid haemorrhage

Sherlock M , O'Sullivan E , Agha A , Behan L , Rawluk D , Brennan P , Thompson C

Hyponatraemia occurs in 25-40% of patients with subarachnoid haemorrhage (SAH) but the pathogenesis is unclear.Objective: We aimed to establish the incidence, pathophysiology and consequences of hyponatraemia following SAH.Methods: A retrospective case note analysis of all patients with radiologically-proven SAH admitted to Beaumont Hospital between Jan 2002 and September 2003. Of 580 patients coded as SAH on HIPE records, 316 were...

ea0007p107 | Endocrine tumours and neoplasia | BES2004

Prevalence of hypopituitarism in patients with prolactin-secreting pituitary microadenomas

Behan L , Seoighe D , Agha A , Sherlock M , Ryan J , Rogers B , Thompson C

Microprolactinomas are considered not to cause pituitary hormone dysfunction, but there is little data available on the prevalence of hormone deficiencies. We aimed to establish the frequency of pituitary hormone dysfunction in patients with hyperprolactinaemia.We examined the casenotes of 124 consecutive patients (85 females) with documented hyperprolactinemia from our pituitary data-base. 52 patients had macroadenomas (tumour > 1cm diameter), 64 mic...

ea0091wd14 | Workshop D: Disorders of the adrenal gland | SFEEU2023

Life-threatening hypokalaemia heralding the diagnosis of metastatic Adrenocortical Cancer (ACC) with 11-deoxycorticosterone hypersecretion

McDonnell Tara , Leanne Cussen , Miller Clare , Moran Carla , Dugal Neil , Sherlock Mark , O'Reilly Michael

A 51 year old presented with headaches, fatigue and generalised weakness. She had a background history of hypertension diagnosed one year prior to presentation. Initial laboratory evaluation demonstrated life-threatening hypokalaemia, potassium 0.9mmol/l(R.I. 3.5-5.3). This profound hypokalaemia required ICU admission for replacement of potassium and monitoring. Management of subsequent fluid overload necessitated a brief period of hemofiltration. During the course of evaluati...

ea0065p13 | Adrenal and Cardiovascular | SFEBES2019

Seasonal vaccination and associated steroid management practice in adrenal insufficiency

O'Murchadha Liam , Dib Liana , Hannon Anne Marie , Dineen Rosemary , Garrahy Aoife , Thompson CJ , Fitzpatrick Fidelma , Sherlock Mark

Background: Adrenal insufficiency remains a potentially life-threatening condition, necessitating adequate glucocorticoid replacement and appropriate stress-related adjustment to avoid crisis. Flu-like illness is a key precipitant of adrenal crisis. While some authorities recommend annual influenza vaccination for such patients, uptake rates in this population are unknown. Additionally, while seasonal vaccines may lead to minor symptoms in the general population, there are no ...

ea0049ep487 | Diabetes (to include epidemiology, pathophysiology) | ECE2017

Lipoprotein particle size in women with type 1 diabetes mellitus and its relationship to carotid intima-media thickness

Gunness Anjuli , Ahmed Mohamed , Pazderska Agnieska , Phelan Niamh , Moore Kevin , Boran Gerard , Behan Lucy-Ann , Sherlock Mark , Gibney James

Although cardiovascular disease (CVD) is greatly increased in type 1 diabetes mellitus (T1DM), patients typically have apparently healthy lipid profiles. Simple measurement of plasma lipids however does not provide information regarding lipoprotein particle size which in the nondiabetic population is independently predictive of CVD. Plasma lipids and lipoprotein subclasses (using polyacrylamide gel-tube electrophoresis) were studied in reproductive age women with T1DM and comp...

ea0041ep877 | Pituitary - Clinical | ECE2016

“The incidence of central adrenal insufficiency in euvolaemic hyponatraemia. Results of a large prospective study”

Cuesta Martin , Slattery David , Garrahy Aoife , Hannon Anne Marie , Tatro Elizabeth , Gupta Saket , Sherlock Mark , Tormey William , Thompson Christopher J

Context: The syndrome of inappropriate antidiuresis(SIAD) is the commonest cause of hyponatraemia. Data on the aetiology of SIAD is mainly derived from retrospective studies, often with poor ascertainment of minimum criteria for correct diagnosis. Although central adrenal insufficiency(CAI) is known to cause euvolaemic hyponatraemia, the incidence of undiagnosed CAI in SIAD is unknown.Objective: To establish the incidence of CAI in SIAD.<p class="abs...

ea0059p135 | Neuroendocrinology and pituitary | SFEBES2018

Bolus 3% saline restores cognitive function more rapidly than traditional slow intravenous infusion of 3% saline in the emergency treatment of SIAD, with symptoms of cerebral irritation

Garrahy Aoife , Dineen Rosemary , Hannon Anne Marie , Zia-ul-Hussnain HM , Cuesta Martin , Sherlock Mark , Thompson Chris

Acute hyponatraemia is a medical emergency with high mortality. Recent expert guidelines advocate treatment with intravenous boluses of 3% saline with the aim to reduce cerebral oedema more rapidly than traditional slow intravenous infusion, but there is a poor evidence base for this policy change. We retrospectively audited treatment of symptomatic hyponatraemia due to SIAD (n=57, age 22–76 year), comparing low dose (20 ml/h) and bolus infusion of 3% saline. Bol...

ea0037oc12.1 | Pituitary – Clinical | ECE2015

The Irish TSHoma study: a multicentre retrospective study

Pazderska Agnieszka , Cuesta Martin , Wallace Helen , Melvin Audrey , Gibney James , Agha Amar , O'Halloran Donal , Hunter Steven , Thompson Chris , Sherlock Mark

TSH-secreting pituitary adenomas (TSHomas) are rare. Previously, the reported prevalence was one case per million populations although this is probably an underestimate. A recently published study reported a prevalence of TSHomas in Sweden of 2.8/million inhabitants.Methods/design: Observational study conducted in four tertiary referral centres in Ireland. We retrospectively collected data on the prevalence, demographics, hormonal profile, tumour charact...

ea0037gp.19.05 | Pituitary–Acromegaly | ECE2015

Clinical and biochemical outcomes during pregnancy in patients with acromegaly

O'Shea Triona , Guptha Saket , Melvin Audrey , McGurran Karen , Casey Ruth , O'Halloran Donal , Gibney James , Thompson Christopher , Sherlock Mark

Acromegaly is a rare condition resulting from excess secretion of GH and IGF1. Acromegaly is frequently associated with subfertility. As such there is little data on the course of the disease during pregnancy, and of the effects of the disease and its treatments on the foetus.Objective: We describe known pregnancies in women with acromegaly within the Republic of Ireland over a 15-year period.Methods: We collected clinical, biochem...